Developing microfluidic technology to radically advance life science research and molecular diagnostics

Stokes Bio Limited was founded in 2005 by Mark Davies and Tara Dalton based on technology developed by the Stokes Research Institute , University of Limerick.

Stokes Bio develops microfluidics technologies for Gene Expression measurement and Gene Target Detection. The products arising from these technologies are used for discovery of markers for cancer, that will lead to a new approach to the diagnosis of cancer, and pathogen detection.